₹4,755.1
▲ +44.28 +0.94%
As of 27 Jul 2026 · delayed
NSE Listed
Pfizer Ltd. (PFIZER)
Volume: 36,458Avg Vol 1W: 22,387.4Avg Vol 1M: 27,26352W Range:₹4,360.1₹5,873.5
Key Ratios
Checked 2d agoMarket Cap₹1,345 Cr
Current Price₹4,755.1
Previous Close₹4,710.82
High / Low (52w)₹5,873.5 / ₹4,360.1
Volume36,458
Avg Vol (1W)22,387.4
Avg Vol (1M)27,263
Stock P/E107.6
Book Value₹918.67
Dividend Yield2.7%
ROE19.8%
ROA33.3%
Revenue (TTM)₹2,708 Cr
Revenue Growth—
Profit Margin19.9%
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹43.68
P/B5.12
Debt / Equity0
50 DMA₹4,557.67
200 DMA₹4,825.39
Day change+0.94%
Price Chart
₹4,755.1▼ 9.89% · 1Y
2025-07-292026-07-27
20-day avg volume: 27K shares
Pros
- Healthy return on equity of 19.8%.
- Pays a dividend yield of 2.7%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 108.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹589 Cr | ₹538 Cr | ₹592 Cr | ₹603 Cr | ₹642 Cr | ₹645 Cr | ₹629 Cr | ₹653 Cr |
| EBITDA | ₹217 Cr | ₹174 Cr | ₹256 Cr | ₹263 Cr | ₹258 Cr | ₹252 Cr | ₹262 Cr | ₹278 Cr |
| Net Profit | ₹158 Cr | ₹128 Cr | ₹331 Cr | ₹192 Cr | ₹189 Cr | ₹142 Cr | ₹200 Cr | ₹204 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,249 Cr | ₹2,336 Cr | ₹2,320 Cr | ₹2,674 Cr | ₹2,526 Cr | ₹2,374 Cr | ₹2,454 Cr | ₹2,708 Cr |
| EBITDA | ₹661 Cr | ₹653 Cr | ₹684 Cr | ₹783 Cr | ₹804 Cr | ₹754 Cr | ₹852 Cr | ₹1,034 Cr |
| Net Profit | ₹429 Cr | ₹509 Cr | ₹498 Cr | ₹613 Cr | ₹624 Cr | ₹551 Cr | ₹768 Cr | ₹722 Cr |
| EPS | 93.78 | 111.28 | 108.77 | 133.89 | 136.38 | 120.51 | 167.79 | 157.92 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,940 Cr | ₹4,405 Cr | ₹3,266 Cr | ₹3,901 Cr | ₹4,001 Cr | ₹4,229 Cr | ₹4,911 Cr | ₹4,922 Cr |
| Total Liabilities | ₹929 Cr | ₹1,010 Cr | ₹873 Cr | ₹1,036 Cr | ₹793 Cr | ₹633 Cr | ₹694 Cr | ₹719 Cr |
| Equity | ₹3,011 Cr | ₹3,395 Cr | ₹2,393 Cr | ₹2,864 Cr | ₹3,207 Cr | ₹3,596 Cr | ₹4,217 Cr | ₹4,203 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | ₹536 Cr | ₹631 Cr | ₹893 Cr | ₹658 Cr | ₹411 Cr | ₹816 Cr | ₹953 Cr |
| Investing | ₹1,530 Cr | ₹-469 Cr | ₹-575 Cr | ₹-36 Cr | ₹54 Cr | ₹-71 Cr | ₹-562 Cr |
| Financing | ₹-164 Cr | ₹-1,571 Cr | ₹-181 Cr | ₹-346 Cr | ₹-235 Cr | ₹-205 Cr | ₹-798 Cr |
| Free Cash Flow | ₹536 Cr | ₹631 Cr | ₹893 Cr | ₹658 Cr | ₹411 Cr | ₹816 Cr | ₹953 Cr |
Shareholding
Promoter 63.92% Institutions 19.45% Public 16.63%
Efficiency & Working Capital
ROCE21.1%
Interest Coverage0
Dividend Payout—
Debtor Days26 d
Inventory Days68 d
Payable Days31 d
Cash Conversion Cycle64 d
Working Capital Days95 d
Shareholding Details
As of 2026-06-30
Promoter63.9%
FII1.7%
DII17.8%
Institutions19.4%
Public16.6%
Promoter Pledge0%
No. of Shareholders1,02,478
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% | 63.9% |
| FIIs | 2.8% | 3% | 3.3% | 3.2% | 3.5% | 2.7% | 2.2% | 2.4% | 2.6% | 2.7% | 2.8% | 1.7% |
| DIIs | 15% | 15.1% | 15.3% | 15.8% | 16% | 16.8% | 17.1% | 17.2% | 17.1% | 17% | 16.9% | 17.8% |
| Public | 18.2% | 17.9% | 17.4% | 17% | 16.5% | 16.5% | 16.8% | 16.5% | 16.4% | 16.3% | 16.4% | 16.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,16,948 | 1,12,456 | 1,09,214 | 1,06,098 | 98,824 | 1,05,015 | 1,08,261 | 1,03,222 | 1,03,480 | 1,00,933 | 99,545 | 1,02,478 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Pfizer East India B V | Shareholding of Promoter and Promoter Group | 39.8% | 1.82 Cr |
| Wyeth Llc | Shareholding of Promoter and Promoter Group | 12.3% | 56,17,707 |
| Nippon Life India Trustee Ltd | Public Shareholding | 4.2% | 19,06,535 |
| Life Insurance Corporation Of India | Public Shareholding | 3.7% | 17,09,223 |
| Wyeth Holdings Corporation | Shareholding of Promoter and Promoter Group | 3.6% | 16,30,164 |
| Icici Prudential Fund | Public Shareholding | 3.3% | 15,14,012 |
| Warner-lambert Company Llc | Shareholding of Promoter and Promoter Group | 2.6% | 11,87,163 |
| Quant Mutual Fund | Public Shareholding | 2.2% | 10,16,315 |
| Atul Limited | Public Shareholding | 2.1% | 9,58,927 |
| Parke, Davis & Company Llc | Shareholding of Promoter and Promoter Group | 2.1% | 9,55,733 |
| John Wyeth & Brother Ltd | Shareholding of Promoter and Promoter Group | 1.9% | 8,82,000 |
| Pharmacia Corporation | Shareholding of Promoter and Promoter Group | 1.7% | 7,83,941 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Pradip Shah | Chairman(Non Exe)&Dir(Non-Ind) | 2026 |
| MEENA GANESH | Independent Non Exe. Director | 2026 |
| L Krishnakumar | Independent Non Exe. Director | 2026 |
| Sonia Singh | Independent Non Exe. Director | 2026 |
| Meenakshi Nevatia | Managing Director & CEO | 2026 |
| Amit Agarwal | Executive Director - Finance / WTD / CFO | 2026 |
| P. Rengan | Executive Director / Whole Time Director | 2026 |
| Prajeet Nair | CS / Director - Corporate Services | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹915 Cr | 87.2% |
| Services | ₹0 Cr | 0% |
| Others | ₹134 Cr | 12.8% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹2,423 Cr | 96.2% |
| outside of India | ₹96 Cr | 3.8% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 53 | 46 | 46 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-28 | Board Meetings | — |
| forthcoming | 2026-07-17 | Dividend (75/- per share) | Final |
| dividend | 2026-07-17 | ₹75 (750%) | Final |
| dividend | 2025-07-09 | ₹35 (350%) | Final |
| dividend | 2025-07-09 | ₹100 (1000%) | Special 1 |
| dividend | 2025-07-09 | ₹30 (300%) | Special 2 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 849 | 0 | 0 | 17 | 485 | 1,352 |
| 2026 | 703 | 0 | 0 | 17 | 485 | 1,205 |
| 2026 | 146 | 0 | 0 | 0 | 0 | 146 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Market28/04/2022 · 9,30,573
Company Information
🌐 www.pfizerindia.com ↗
📍 The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E, Mumbai, Maharashtra, 400051
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Peninsula Land LimitedPentagon Rubber LimitedPerfect Infraengineer Ltd.Persistent Systems Ltd.Petronet LNG LimitedPower Finance Corporation Ltd.3M Ois Spread 2.33 BpsPrime Focus LimitedPTC India Financial Services Ltd.PG Electroplast Ltd.Procter & Gamble Hygiene and Health Care Ltd.Procter & Gamble Health LimitedAll “P” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search